Serial analysis of soluble intercellular adhesion molecule-1 level in relapsing-remitting multiple sclerosis patients during IFN-β1b treatment

Journal of Interferon and Cytokine Research

Volumn 23, Issue 3, 2003, Pages 127-133

  Kilinc, Munire ^a   Saatci Cekirge, Isil ^b   Karabudak, Rana ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERFERON BETA SERINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RECURRENT DISEASE; REMISSION;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE; SOLUBILITY; TIME FACTORS;

EID: 0037356044     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999003321532457     Document Type: Article

References (30)

1. RAINE, C.S. (1991). Demyelinating diseases. In: Textbook of Neuropathology, 2nd ed. R.L. Davis and D.M. Robertson (eds.) Baltimore: Wilkins & Wilkins, pp. 535-620.
2. SELMAJ, K. (1996). Pathophysiology of the blood-brain barrier. Semin. Immunopathol. 18, 57-73.
3. SHIMIZU Y., NEWMAN, W., TANAKA, Y., and SHAW, S. (1992). Lymphocyte interactions with endothelial cells. Immunol. Today 13, 106-110.
4. DORE-DUFFY, P., NEWMAN, W., BALABANOV, R., LISAK, R.P., MAINOLFI, E., ROTHLEIN, R., and PETERSON, M. (1995). Circulating soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann. Neurol. 37, 55-62.
5. HARTUNG, H.P., MICHELS, M., REINERS, K., SEELDRAYERS, P., ARCHELOS, J.J., and TOYKA, K.V. (1993). Soluble ICAM-1 levels in multiple sclerosis and viral encephalitis. Neurology 43, 2331-2335.
6. DEFAZIO, G., LIVREA, P., GIORELLI, M., MARTINO, D., ROSELLI, F., RICCHIUTI, F., and TROJANO, M. (2000). Interferon beta-1b downregulates TNF-alpha-induced intercellular adhesion molecule 1 expression on brain microvascular endothelial cells through a tyrosine kinase-dependent pathway. Brain Res. 881, 227-230.
7. TROJANO, M., AVOLIO, C., SIMONE, L., DEFAZIO, G., MANZARI, C., ROBERTIS, F., CALO, A., and LIVREA, P. (1996). Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings. Neurology 47, 1535-1541.
8. RIECKMANN, P., MARTIN, S., WEICHSELBRAUN, I., ALBRECHT, M., KITZE, B., WEBER, T., TUMANI, H., BROOCKS, A., LÜER, W., HELWIG, A., and POSER, S. (1994). Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 44, 2367-2372.
9. RIECKMANN, P., MICHEL, U., ALBRECHT, M., BRÜCK, W., WÖCKEL, L., and FELGENHAUER, K. (1995). Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J. Neuroimmunol. 60, 9-15.
10. BROD, S.A., MARSHALL, G.D., HENNIGER, E.M., SRIRAM, S., KHAN, M., and WOLINSKY, J.S. (1996). IFN-β1b treatment decreases TNF and increases IL-6 production in MS. Neurology 46, 1633-1638.
11. TROJANO, M., AVOLIO, C., SIMONE, I.L., RUGGIERI, M., DEFAZIO, G., GIULIANI, F., PAOLICELLI, D., and LIVREA, P. (1997). Anti-inflammatory effects of rIFN-β1b in MS: longitudinal changes of the serum soluble ICAM-1, TNF-α and T cell subsets. Neurology 48S, A244.
12. TROJANO, M., AVALIO, C., RUGGIERI, M., DEFAZIO, G., GIULIANI, F., PAOLICELLI, D., and LIVREA, P. (1998). Serum-soluble intercellular adhesion molecule-1 in MS: relation to clinical and Gd-MR activity and to rIFN beta-1b treatment. Mult. Scler. 4, 183-187.
13. TROJANO, M., AVOLIO, C., LUIZZI, G., RUGGIERI, M., DEFAZIO, G., LIGUORI, M., SANTACROSE, M., PAOLIECELLI, M., GUILIANI, F., RICCI, P., and LIVREA, P. (1999). Changes of serum sICAM-1 and MMP-9 induced by rIFN-β1b treatment in relaping-remitting MS. Neurology 53, 1402-1408.
14. GAYO, A., MOZO, L., SUAREZ, A., TUNON, A., LAHOZ, C., and GUTIERREZ, C. (1999). Interferon beta-1b treatment modulates TNF alpha and IFN gamma spontaneous gene expression in MS. Neurology 52, 1764-1770.
15. TROJANO, M., DEFAZIO, G., AVALIO, C., PAOLICELLI, D., GIULIANI, F., GIORELLI, M., and LIVREA, P. (2000). Effects of rIFN-beta1b on serum circulating ICAM-1 in relapsing-remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells. J. Neurovirol. 6(Suppl. 2), S47-51.
16. OZENCI, V., KOUWENHOVEN, M., TELESHOVA, N., PASHENKOV, M., FREDRIKSON, S., and LINK, H. (2000). Multiple sclerosis: pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta. J. Neuroimmunol. 108, 236-243.
17. POSER, C.M., PATTY, D.W., SCHEINBERG, L., McDONALD, W.I., DAVIS F.A., EBERS, G.C., JOHNSON, K.P., SIBLEY, W.A., SILBERBERG, D.H., and TOURTELLOTTE, W.W. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
18. GIOVANNI, G., LAI, M., KIDD, D., CHAMOUN, V., THOMPSON, A.J., MILLER, D.H., FELDMAN, M., and THOMPSON, E.J. (1997). Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium-enhanced magnetic resonance imaging. Neurology 48, 1557-1565.
19. TSUKADA, N., MIYAGI, K., MATSUDA, M., and YANAGISAWA, N. (1993). Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type-1 associated myelopathy. Ann. Neurol. 33, 646-649.
20. TSUKADA, N., MATSUDA, M., MIYAGI, K., and YANAGISAWA, N. (1993). Increased levels of ICAM-1 and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology 43, 2679-2682.
21. SHARIEF, M.K., and THOMPSON, E.J. (1992). In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with multiple sclerosis. J. Neuroimmunol. 38, 27-34.
22. SHARIEF, M., PHIL, M., and ENTGES, R. (1991). Association between tumor necrosis factor α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325, 467-472.
23. FRANCIOTTA, D.M., GRIMALDI, L.M.E., MARTINO, G.V., PICCOLO, G., BERGAMASCHI, R., CITTERIO, A., and MELZI D'ERIL, G.V. (1989). Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 26, 787-789.
24. SHARIEF, M.K., NOORI, M.A., CIARDI, M., CIRELLI, A., and THOMPSON, E.J. (1993). Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage. J. Neuroimmunol. 43, 15-22.
25. ARNASON, B.G.W., DAYAL, Q.Z.X., JENSEN, M.A., GENÇ, K., and REDER, A. (1996). Mechanism of action of IFN-β1b in multiple sclerosis. Semin. Immunopathol. 18, 125-148.
26. DEFAZIO, G., TROJANO, M., RIBATTI, D., NICO, B., GIORELLI, M., DE SALVIA, R., RUSSO, G., RONCALI, L., and LIVREA, P. (1998). ICAM-1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon β-1a and TNFα. J. Neuroimmunol. 88, 13-20.
27. LOU, J., GASCHE, Y., ZHENG, L., GIROUD, C., MOREL, P., CLEMENTS, J. YTHIER, A., and GRAU, G.E. (1999). Interferon-beta inhibits activated leucocyte migration through human microvascular endothelial cell monolayer. Lab. Invest. 79, 1015-1025.
28. CALABRESI, P.A., TRANQUILL, L.R., DAMBROSIA, J.M., STONE, L.A., MALONI, H., BASH, C.N., FRANK, J.A., and McFARLAND, H.F. (1997). Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β-1b. Ann. Neurol. 41, 669-674.
29. ARCHELOS, J., JUNG, S., MAURER, M., SCHMIED, M., LASSMANN, H., TAMATANI, T., MIYASAKA, M., TOYKA, K., and HARTUNG, H. (1993). Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34, 145-154.
30. KHOURY, S.J., ORAV, E.J., GUTTMANN, C.R.G., KIKINIS, R., JOLESZ, F.A., and WEINER, H.L. (1999). Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis. Neurology 53, 758-764.